In a recent study investigating the effects of prostaglandin E1 (PGE1) on reducing inspired oxygen concentration during one-lung ventilation (OLV), several key findings and outcomes were identified.
Acute respiratory distress syndrome is a significant complication in critical care patients. COVID-19 (C19)-associated severe respiratory failure is related to it, and d-dimer rise predicts a worse ...
The following is a summary of “Clinical Performance of Spo 2 /Fio 2 and Pao 2 /Fio 2 Ratio in Mechanically Ventilated Acute Respiratory Distress Syndrome Patients: A Retrospective Study,” published in ...
Lungpacer Medical, the award-winning medical device company founded by BPK professor Andy Hoffer in 2009 and spun out from the SFU Neurokinesiology Lab in 2014, achieved a key milestone on December 5, ...
Lung ultrasound is a developing and beneficial method for identifying compromised alveolar air and the presence of interstitial and alveolar fluid. It assesses lung aeration beyond the pleura and can ...
The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.
The models use maximal deflection of esophageal pressure to quantify HFOT-related breathing effort (ΔPes) and the risk for strong breathing effort (ΔPes >10 cmH2O). Two models have been developed to ...
The P/F ratio, also known as the PaO2/FiO2 ratio, is a valuable tool for evaluating oxygenation status in critically ill patients. It is commonly used to determine the severity of acute respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results